The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a promising advance. Unlike injections, this approach offers a simpler way to provide GLP-1 therapies. These https://philipddqc367584.dm-blog.com/41274980/glp-1-patches-a-new-approach-to-blood-sugar-management